Yield10 Bioscience, Inc.
YTEN · NASDAQ
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Revenue | $450 | $300 | $60 | $0 |
| % Growth | 50% | 400% | – | – |
| Cost of Goods Sold | $0 | $0 | $73 | $72 |
| Gross Profit | $450 | $300 | -$13 | -$72 |
| % Margin | 100% | 100% | -21.7% | – |
| R&D Expenses | $1,649 | $1,366 | $1,960 | $2,204 |
| G&A Expenses | $2,004 | $1,374 | $1,287 | $1,499 |
| SG&A Expenses | $2,004 | $1,374 | $1,214 | $1,499 |
| Sales & Mktg Exp. | $0 | $0 | -$73 | $0 |
| Other Operating Expenses | $0 | $0 | -$19 | -$23 |
| Operating Expenses | $3,653 | $2,740 | $3,174 | $3,703 |
| Operating Income | -$3,203 | -$2,440 | -$3,247 | -$3,703 |
| % Margin | -711.8% | -813.3% | -5,411.7% | – |
| Other Income/Exp. Net | -$35 | -$32 | -$19 | -$23 |
| Pre-Tax Income | -$3,238 | -$2,472 | -$3,266 | -$3,726 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3,238 | -$2,472 | -$3,266 | -$3,726 |
| % Margin | -719.6% | -824% | -5,443.3% | – |
| EPS | -5.04 | -4.77 | -6.54 | -9.95 |
| % Growth | -5.7% | 27.1% | 34.3% | – |
| EPS Diluted | -5.04 | -4.77 | -6.54 | -9.95 |
| Weighted Avg Shares Out | 642 | 519 | 499 | 374 |
| Weighted Avg Shares Out Dil | 642 | 519 | 499 | 374 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $18 | $0 |
| Depreciation & Amortization | $60 | $66 | $73 | $72 |
| EBITDA | -$3,143 | -$2,374 | -$3,174 | -$3,631 |
| % Margin | -698.4% | -791.3% | -5,290% | – |